With Vascepa’s New CV Claim, Amarin Targets Patients On Other Triglyceride-Lowering Agents

 
• By Sue Sutter
  
Fishing rod wheel closeup, man fishing with a beautiful sunrise behind him
Amarin finally has reeled in the big indication for Vascepa in the US. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip